Surgical Science Offer
Rule 2.7 Announcement
Surgical Science – Nasdaq Announcement to 2.7 (18 Dec 24) (vF)
Surgical Science – Nasdaq Announcement to 2.7 (SWE) (18 Dec 24) (vF)
Surgical Science – Investor Presentation (vF)
Confidentiality Agreement(457032830.1)
Co-operation Agreement (Redacted)
Irrevocable Undertaking from Stuart Gall (Director)
Irrevocable Undertaking from Helen Jones (Director)
Irrevocable Undertaking from Ingeborg Dybdal Oie (Director)
Irrevocable Undertaking from Riccardo Pigliucci (Director)
Irrevocable Undertaking from Nicholas Avis (Director)
Irrevocable Undertaking from Parkwalk Advisors Ltd (Shareholder)
Irrevocable Undertaking from IP2IPO Limited (Shareholder)
Irrevocable Undertaking from IP Venture Fund II (GP) LLP (Shareholder)
Irrevocable Undertaking from IP2IPO Portfolio (GP) Limited (Shareholder)
Irrevocable Undertaking from Polar Capital Global Healthcare Trust plc (Shareholder)
Letter of Intent from Amati Global Investors Limited (Shareholder)
Consent Letter – Pareto Securities AB (Redacted)
Consent Letter – Strand Hanson (Redacted)
Consent Letter – Cavendish Capital Markets Limited (Redacted)
Danske Bank Facility (in Swedish, with English translation)(Redacted)
Rule 2.11 Letter to employees – Project Saturn – (dated)_Redacted
Rule 2.11 Letter to shareholders – Project Saturn (dated)_Redacted